GenFleet Therapeutics
Pharmaceutical ManufacturingView the employees at
GenFleet Therapeutics-
Xin Li Genfleet Therapeutics - Associate Director, pharmacology
-
Shanghai, China
-
Rising Star
Yingxue Wang GenFleet Therapeutics - RA Director-
Rising Star
Qingyang L. Formulation Scientist II-
Germany
-
Rising Star
Amy S. Overseas Payroll/ CO HRBP-
Rising Star
Yuanyuan Xie GenFleet Therapeutics - Executive Director of CMC Development-
Pudong, Shanghai, China
-
Rising Star
Overview
Dedicated to serving significant unmet medical needs, GenFleet Therapeutics constructs its R&D platform on the basis of disease biology and translational medicine, and researches into latest biological mechanism of cancer pathways, tumor microenvironment and human immunoregulation. GenFleet's rich and diversified pipeline highlights multiple cutting-edge products with novel mechanisms and global intellectual property rights. Through years of endeavor, GenFleet has set up industry-leading capabilities and expertise in developing novel drugs - both small molecules and biologics. Its cutting-edge pipeline includes over 10 products, three of which have progressed into clinical stages. As more projects move into late-stage clinical trials, GenFleet is expected to unravel its blueprint of commercialization during the next 3-5 years.
-